...
首页> 外文期刊>Radiation Oncology Journal >Induction Chemotherapy Plus Radiation Compared with Surgery Plus Radiation in Patients with Advanced Laryngeal and Hypopharyngeal Cancer
【24h】

Induction Chemotherapy Plus Radiation Compared with Surgery Plus Radiation in Patients with Advanced Laryngeal and Hypopharyngeal Cancer

机译:晚期喉和下咽喉癌患者的诱导化疗加放疗与手术加放疗比较

获取原文
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: We performed a retrospective study in patients with previously untreated advanced(Stage III or IV) laryngeal and hypopharyngeal cancer to compare the results of induction chemotherapy followed by definitive radiation therapy (CT+RT) with those of conventional laryngectomy and postoperative radiation therapy (OP+RT). METHOD: Between 1985 and 1990, twenty four patients were treated with two or three courses of chemotherapy and radiation therapy(66~75 Gy). Twenty-five patients were received laryngectomy and radical neck dissection(except 3 patients) and postoperative radiation therapy (55~04 Gy). RESULT: After a median follow-up of 20 months, the actuarial 5-year overall survival rate was 24% (chemotherapy group) and 36% (op group).(P>0.1). The local control rate was the 65%,(13/20) and 68.2%(15/22).(P>0.1). The rate of laryngeal preservation was 65%(13/20) in chemotherapy group. CONCLUSION: Induction chemotherapy and definitive radiation therapy can be effective in preserving the larynx in a high percentage of patients with advanced laryngeal and hypopharyngeal cancer.
机译:背景:我们对先前未经治疗的晚期(III期或IV期)喉和下咽癌患者进行了一项回顾性研究,以比较诱导化疗后行定性放射治疗(CT + RT)与常规喉切除术和术后放射治疗的结果( OP + RT)。方法:在1985年至1990年期间,对24例患者进行了两,三个疗程的化疗和放疗(66〜75 Gy)。 25例患者接受了喉癌切除术和根治性颈淋巴结清扫术(3例除外)和术后放疗(55〜04 Gy)。结果:中位随访20个月后,精算5年总生存率为24%(化疗组)和36%(op组)。(P> 0.1)。局部控制率为65%(13/20)和68.2%(15/22)。(P> 0.1)。化疗组喉保存率达65%(13/20)。结论:诱导化疗和确定性放射治疗可以有效地保留高比例的晚期喉癌和下咽癌患者的喉部。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号